Vinca Alkaloids and Analogs

Vinca alkaloids and analogs are a class of antineoplastic agents derived naturally from the periwinkle plant (*Catharanthus roseus*) or produced as semisynthetic derivatives They function as cell cycle M-phase–specific antimitotic drugs by binding directly to tubulin, which inhibits microtubule polymerization and halts mitotic spindle assembly, ultimately arresting cellular division and inducing apoptotic cell death

Vinca alkaloids and analogs are a class of antineoplastic agents derived naturally from the periwinkle plant (*Catharanthus roseus*) or produced as semisynthetic derivatives Agents in this class—such as vincristine, vinblastine, and vinorelbine—serve key therapeutic roles across multi-agent chemotherapy regimens for hematologic malignancies, including acute leukemias and lymphomas, as well as solid tumors such as non-small cell lung cancer, breast cancer, and various pediatric cancers

They function as cell cycle M-phase–specific antimitotic drugs by binding directly to tubulin, which inhibits microtubule polymerization and halts mitotic spindle assembly, ultimately arresting cellular division and inducing apoptotic cell death Agents in this class—such as vincristine, vinblastine, and vinorelbine—serve key therapeutic roles across multi-agent chemotherapy regimens for hematologic malignancies, including acute leukemias and lymphomas, as well as solid tumors such as non-small c...

They function as cell cycle M-phase–specific antimitotic drugs by binding directly to tubulin, which inhibits microtubule polymerization and halts mitotic spindle assembly, ultimately arresting cellular division and inducing apoptotic cell death

Agents in this class—such as vincristine, vinblastine, and vinorelbine—serve key therapeutic roles across multi-agent chemotherapy regimens for hematologic malignancies, including acute leukemias and lymphomas, as well as solid tumors such as non-small cell lung cancer, breast cancer, and various pediatric cancers

Agents in this class—such as vincristine, vinblastine, and vinorelbine—serve key therapeutic roles across multi-agent chemotherapy regimens for hematologic malignancies, including acute leukemias and lymphomas, as well as solid tumors such as non-small cell lung cancer, breast cancer, and various pediatric cancers